Alveus Therapeutics
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $197M
Investors
- 7
About Alveus Therapeutics
Alveus Therapeutics, founded in 2023 and headquartered in Philadelphia, US, is dedicated to developing advanced therapies for obesity and related conditions.Alveus Therapeutics specializes in developing advanced therapeutic solutions aimed at addressing obesity and related metabolic diseases. The company’s primary focus is on a differentiated portfolio of next-generation metabolic therapies, with its lead asset, ALV-100, currently in Phase 2 clinical trials. This therapeutic candidate is designed to promote sustainable weight loss while ensuring superior tolerability for patients—a critical challenge in the obesity treatment landscape. Additionally, Alveus is advancing a preclinical pipeline of amylin-based therapies, which includes best-in-class peptides, oral small molecules, and innovative formats that target optimal weight loss quality. The company’s revenue generation model is rooted in partnerships with healthcare organizations and pharmaceutical firms, which may include licensing agreements or collaborations for the development and distribution of its products. The company is also progressing additional R&D programs aimed at enhancing its portfolio.
Who invested in Alveus Therapeutics
7 investors across 1 round
See all investors in Alveus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 8, 2026
Amount
$197M
Investors
Questions about Alveus Therapeutics
Who invested in Alveus Therapeutics?
Alveus Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alveus Therapeutics raised?
Alveus Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alveus Therapeutics last raise money?
Alveus Therapeutics's most recent round on record is a Series A, in Jan 2026.
What does Alveus Therapeutics do?
Alveus Therapeutics, founded in 2023 and headquartered in Philadelphia, US, is dedicated to developing advanced therapies for obesity and related conditions.
Where is Alveus Therapeutics headquartered?
Alveus Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Alveus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back companies at Alveus Therapeutics's stage. Their profiles are linked below.
VCs to look at next
Raising like Alveus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.